pubmed-article:9060563 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1516476 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0002210 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0206624 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C0449243 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1704240 | lld:lifeskim |
pubmed-article:9060563 | lifeskim:mentions | umls-concept:C1519810 | lld:lifeskim |
pubmed-article:9060563 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:9060563 | pubmed:dateCreated | 1997-3-31 | lld:pubmed |
pubmed-article:9060563 | pubmed:abstractText | We analyzed data on 31 children with primary unresectable or metastatic hepatoblastoma (HB) to investigate possible prognostic correlations between the serum level of alpha-fetoprotein (AFP), its changes during treatment, and outcome. | lld:pubmed |
pubmed-article:9060563 | pubmed:language | eng | lld:pubmed |
pubmed-article:9060563 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9060563 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9060563 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9060563 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9060563 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9060563 | pubmed:month | Mar | lld:pubmed |
pubmed-article:9060563 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:HammondG DGD | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:OrtegaJ AJA | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:FeusnerJ HJH | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:KingD RDR | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:BuckleyJ DJD | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:QuinnJ JJJ | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:9060563 | pubmed:author | pubmed-author:KrailoM DMD | lld:pubmed |
pubmed-article:9060563 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9060563 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:9060563 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9060563 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9060563 | pubmed:pagination | 1190-7 | lld:pubmed |
pubmed-article:9060563 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:meshHeading | pubmed-meshheading:9060563-... | lld:pubmed |
pubmed-article:9060563 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9060563 | pubmed:articleTitle | Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. | lld:pubmed |
pubmed-article:9060563 | pubmed:affiliation | Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, USA. | lld:pubmed |
pubmed-article:9060563 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9060563 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9060563 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9060563 | lld:pubmed |